Portfolio company
Vapogenix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Vapogenix develops topical non-opioid analgesics to treat localised pain from wounds and inflammatory conditions for patients requiring non-narcotic relief.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PainReform
This pharmaceutical company develops extended-release anesthetic formulations to provide post-operative pain relief for surgical patients and reduce opioid dependency.
Latigo Biotherapeutics
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.
Mimetic Medicines
This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.
Vaporox
This company develops medical devices for healing chronic wounds by delivering concentrated oxygen and water vapor to healthcare facilities and clinics.
Latigo
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.
Centrexion Therapeutics
This biopharmaceutical company develops non-opioid and non-addictive therapies for patients with chronic pain conditions like osteoarthritis and diabetic neuropathy.
Centrexion
Centrexion develops non-opioid, non-addictive therapies for the treatment of chronic pain and autoimmune diseases for patients with unmet medical needs.
Brixton Biosciences
This life sciences company develops a nerve-selective injectable biomaterial that provides long-lasting, drug-free pain relief for patients suffering from chronic and acute orthopedic conditions.
